Blogs
News
-
Collaborations | 04 Nov, 2026
Porton Advanced and Neoantigen Therapeutics Announce Strategic Partnership to Advance Phase II Program for mRNA Personalized Cancer Vaccines
-
Collaborations | 23 Oct, 2026
Porton Advanced Partners with Ascist Biotech to Accelerate IND Submission for Adult Pancreatic Progenitor Cell Therapy in Diabetes












